Finance Monthly CFO Awards 2016 Winners Edition

www.finance-monthly.com Manmeet S. Soni CFO at ARIAD Pharmaceuticals, Inc. About Manmeet S. Soni Manmeet S. Soni, joined ARIAD in March 2016 as the Company’s Executive Vice President, Chief Financial Officer and Treasurer. Since joining ARIAD Mr. Soni has had a profound impact, overseeing the company’s finance, corporate communications and investor relations, information technology and facilities departments. During his tenure he has been a leader in the Company’s rapid progress in transforming its strategy, culture and financial position, most visibly with the Company’s successful divestiture of its European operations and outlicense of its approved drug for refractory chronic myeloid leukemia to Incyte. This major transaction helped ARIAD significantly improve its cash position/financial profile, reduce operating costs ~ $65 million annually and to continue the royalty stream of its approved product while having strategic flexibility for the future. Mr. Soni joined ARIAD from Pharmacyclics, where most recently he served as Chief Financial Officer until September 2015 having overall responsibility for finance, accounting, business development, procurement, IT, HR and commercial operations. While at Pharmacyclics, Mr. Soni was instrumental in securing its sale to AbbVie for more than $20 billion. Before taking over CFO responsibility at Pharmacyclics, he also served as Corporate Controller. Pharmacyclics was acquired by AbbVie, Inc. in May 2015. Prior to joining Pharmacyclics in 2012, Mr. Soni worked at ZELTIQ Aesthetics Inc., where he served as controller and senior director of finance. Mr. Soni began his career at PricewaterhouseCoopers, India in 2001 and then in 2007 moved to PricewaterhouseCoopers San Jose, in the Life Science and Venture Capital Group. Mr. Soni currently serves on the board of Genoscience Pharma. He graduated from Hansraj College at Delhi University in India. He is a Certified Public Accountant, licensed in the State of California. He also completed his Chartered Accountancy from the Institute of Chartered Accountant of India. Firm Profile ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts is focused on discovering, developing and commercializing precision therapies for patients with rare cancers. ARIAD is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. ARIAD is focused on becoming a leading discoverer and developer of small-molecule medicines to treat patients in the greatest areas of medical need. Equally important is to be known for the highest standards of integrity and stewardship in serving patients, the medical community, employees and shareholders. ARIAD is making that vision a reality: · By attracting, developing and retaining the best and brightest minds—building upon our solid team of people, seeking individuals from diverse backgrounds in drug discovery, development and commercialization, financial management, and business strategy. · By leveraging ARIAD’s strengths—scientific excellence and clinical scholarship—to broadly develop our lead oncology product candidates and build a pipeline of innovative follow-on product candidates. · By building a world-class commercial organization to bring our new medicines to cancer patients on a global basis. USA Finance Monthly CFO Awards 2016 Contact Details Manmeet S. Soni CFO at ARIAD Pharmaceuticals, Inc., Web: www.ariad.com 41